Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model
In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, an...
Saved in:
Published in | Environmental and ecological statistics Vol. 18; no. 1; pp. 131 - 146 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.03.2011
Springer Nature B.V Springer Verlag (Germany) |
Subjects | |
Online Access | Get full text |
ISSN | 1352-8505 1573-3009 |
DOI | 10.1007/s10651-009-0124-1 |
Cover
Abstract | In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata. |
---|---|
AbstractList | In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata. In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata. In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7–17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64–1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata. In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.[PUBLICATION ABSTRACT] In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata. |
Author | Mezzetti, Maura Smith, Thomas J Ngo, Long Ryan, Louise M Bois, Frédéric Y |
Author_xml | – sequence: 1 fullname: Ngo, Long – sequence: 2 fullname: Ryan, Louise M – sequence: 3 fullname: Mezzetti, Maura – sequence: 4 fullname: Bois, Frédéric Y – sequence: 5 fullname: Smith, Thomas J |
BackLink | https://ineris.hal.science/ineris-00963266$$DView record in HAL |
BookMark | eNqFkk1v1DAQhi1UJNqFH8CJiAscCIwdf8THtioUaSUO0LM1GztblyRebAcp_x5HQSBxKAdrrJlnXvkdzwU5m8LkCHlJ4T0FUB8SBSloDaBroIzX9Ak5p0I1dVNSZ-XeCFa3AsQzcpHSAwBwysQ5yTcp-xGzn47V6DIewuC7KmJ2VR9idZgzWu8mV2GuUnZolxLW6pzWFqyucHHJ41Sd7pfkwxCOvsNhWOoDJmdLFuOIXfjuJ5eL8hisG56Tpz0Oyb34HXfk7uPNt-vbev_l0-fry33dcalzzfq-uOKWMWxVS5lT4Kzlh77TUljLROOgV51kWotOU6FLjUsnLYBomaXNjrzbdO9xMKdYfMbFBPTm9nJvyoOiT6aMRzZMyp8r_mbDTzH8mF3KZvSpc8OAkwtzMq3kjdZKqUK-fZSkBaIKuJL_R6VshAZetHfk9T_oQ5jjVCZkWsFp-U61QnSDuhhSiq7_Y4yCWVfBbKuwGjPrKpjVGNt6UmGno4t_hR9rerU19RgMHtdZ3X1lQDmUw5SQzS9rR8Ch |
Cites_doi | 10.1080/15298668791385723 10.1289/ehp.02110165 10.1016/0300-483X(96)03462-2 10.1016/0300-483X(96)03464-6 10.1016/0300-483X(96)03463-4 10.1289/ehp.102-1567096 10.1016/0300-483X(96)03466-X 10.2307/3454324 10.1289/ehp.01109921 10.1016/0300-483X(96)03461-0 10.1093/carcin/14.4.619 10.1016/0300-483X(96)03465-8 10.1093/toxsci/49.2.213 10.2307/2291566 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC 2009 Springer Science+Business Media, LLC 2011 Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Springer Science+Business Media, LLC 2009 – notice: Springer Science+Business Media, LLC 2011 – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | FBQ AAYXX CITATION 3V. 7SN 7ST 7UA 7WY 7WZ 7XB 87Z 88I 8AL 8FD 8FE 8FG 8FH 8FK 8FL ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BEZIV BGLVJ BHPHI BKSAR C1K CCPQU DWQXO F1W FR3 FRNLG F~G GNUQQ H97 HCIFZ JQ2 K60 K6~ K7- L.- L.G LK8 M0C M0N M2P M7P P5Z P62 P64 PATMY PCBAR PHGZM PHGZT PKEHL PQBIZ PQBZA PQEST PQGLB PQQKQ PQUKI PYCSY Q9U RC3 SOI 7S9 L.6 7SU KR7 1XC |
DOI | 10.1007/s10651-009-0124-1 |
DatabaseName | AGRIS CrossRef ProQuest Central (Corporate) Ecology Abstracts Environment Abstracts Water Resources Abstracts ABI/INFORM Collection ABI/INFORM Global (PDF only) ProQuest Central (purchase pre-March 2016) ABI/INFORM Global (Alumni Edition) Science Database (Alumni Edition) Computing Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Business Premium Collection Technology Collection (via ProQuest SciTech Premium Collection) Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database Business Premium Collection (Alumni) ABI/INFORM Global (Corporate) ProQuest Central Student Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality SciTech Premium Collection ProQuest Computer Science Collection ProQuest Business Collection (Alumni Edition) ProQuest Business Collection Computer Science Database ABI/INFORM Professional Advanced Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest Biological Science Collection ABI/INFORM Global Computing Database Science Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Earth, Atmospheric & Aquatic Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest One Business (OCUL) ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Environmental Science Collection ProQuest Central Basic Genetics Abstracts Environment Abstracts AGRICOLA AGRICOLA - Academic Environmental Engineering Abstracts Civil Engineering Abstracts Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef ProQuest Business Collection (Alumni Edition) Computer Science Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection SciTech Premium Collection ABI/INFORM Complete Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Water Resources Abstracts Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Natural Science Collection Biological Science Collection ProQuest Central (New) Advanced Technologies & Aerospace Collection Business Premium Collection ABI/INFORM Global ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database ProQuest Technology Collection Biological Science Database ProQuest Business Collection Ecology Abstracts Biotechnology and BioEngineering Abstracts Environmental Science Collection ProQuest One Academic UKI Edition Environmental Science Database Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ABI/INFORM Global (Corporate) ProQuest One Business Aquatic Science & Fisheries Abstracts (ASFA) Professional Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Central Earth, Atmospheric & Aquatic Science Collection ABI/INFORM Professional Advanced Genetics Abstracts ProQuest Central Korea Agricultural & Environmental Science Collection ABI/INFORM Complete (Alumni Edition) ProQuest Computing ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest Computing (Alumni Edition) ProQuest SciTech Collection Advanced Technologies & Aerospace Database ASFA: Aquatic Sciences and Fisheries Abstracts ProQuest One Business (Alumni) Environment Abstracts ProQuest Central (Alumni) Business Premium Collection (Alumni) AGRICOLA AGRICOLA - Academic Civil Engineering Abstracts Environmental Engineering Abstracts |
DatabaseTitleList | AGRICOLA ProQuest Business Collection (Alumni Edition) Civil Engineering Abstracts Civil Engineering Abstracts |
Database_xml | – sequence: 1 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database – sequence: 2 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Geology Statistics Environmental Sciences Medicine Computer Science Ecology Physics Public Health |
EISSN | 1573-3009 |
EndPage | 146 |
ExternalDocumentID | oai_HAL_ineris_00963266v1 2279085571 10_1007_s10651_009_0124_1 US201400142756 |
Genre | Feature |
GroupedDBID | -4W -56 -5G -BR -EM -Y2 -~C .86 .VR 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 3-Y 30V 3V. 4.4 406 408 409 40D 40E 4P2 53G 5GY 5QI 5VS 67M 67Z 6NX 78A 7WY 7XC 88I 8CJ 8FE 8FG 8FH 8FL 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTAH ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACGOD ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOAH ADOXG ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFEXP AFGCZ AFKRA AFLOW AFNRJ AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AOSHJ ARAPS ARMRJ ASPBG ATCPS AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BEZIV BGLVJ BGNMA BHPHI BKSAR BPHCQ CAG CCPQU COF CS3 CSCUP D1J DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EDH EIOEI EJD ESBYG FBQ FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRNLG FRRFC FSGXE FWDCC GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GROUPED_ABI_INFORM_COMPLETE GXS HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ H~9 I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K60 K6V K6~ K7- KDC KOV KOW L8X LAK LK8 LLZTM M0C M0N M2P M4Y M7P MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P62 PATMY PCBAR PF0 PQBIZ PQQKQ PROAC PT4 PT5 PYCSY Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK6 WK8 YLTOR Z45 ZMTXR ZOVNA ZY4 ~02 ~A9 ~EX ~KM AACDK AAHBH AAJBT AASML AAYZH ABAKF ABQSL ACAOD ACDTI ACPIV ACZOJ AEFQL AEMSY AEUYN AFBBN AGQEE AGRTI AIGIU BSONS H13 PQBZA AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT 7SN 7ST 7UA 7XB 8AL 8FD 8FK ABRTQ C1K F1W FR3 H97 JQ2 L.- L.G P64 PKEHL PQEST PQGLB PQUKI Q9U RC3 SOI 7S9 L.6 PUEGO 7SU KR7 1XC |
ID | FETCH-LOGICAL-c469t-2ff1064d22a87812e70edd4bfc965dd253e0f7c62995c9159d4b46e6d00582d13 |
IEDL.DBID | 8FG |
ISSN | 1352-8505 |
IngestDate | Fri May 09 12:27:40 EDT 2025 Thu Sep 04 19:28:48 EDT 2025 Thu Sep 04 22:29:03 EDT 2025 Thu Sep 04 23:46:41 EDT 2025 Fri Jul 25 19:05:39 EDT 2025 Tue Jul 01 04:38:00 EDT 2025 Fri Feb 21 02:42:01 EST 2025 Wed Dec 27 19:25:38 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Bayesian hierarchical model Compartmental model Differential equation Random effects Markov Chain Monte Carlo Metabolic rate constant Steady state Nonlinear model |
Language | English |
License | http://www.springer.com/tdm Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c469t-2ff1064d22a87812e70edd4bfc965dd253e0f7c62995c9159d4b46e6d00582d13 |
Notes | http://dx.doi.org/10.1007/s10651-009-0124-1 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
OpenAccessLink | http://hdl.handle.net/2108/37091 |
PQID | 854115774 |
PQPubID | 23500 |
PageCount | 16 |
ParticipantIDs | hal_primary_oai_HAL_ineris_00963266v1 proquest_miscellaneous_864399777 proquest_miscellaneous_1777170476 proquest_miscellaneous_1663590464 proquest_journals_854115774 crossref_primary_10_1007_s10651_009_0124_1 springer_journals_10_1007_s10651_009_0124_1 fao_agris_US201400142756 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-03-01 |
PublicationDateYYYYMMDD | 2011-03-01 |
PublicationDate_xml | – month: 03 year: 2011 text: 2011-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: Dordrecht |
PublicationTitle | Environmental and ecological statistics |
PublicationTitleAbbrev | Environ Ecol Stat |
PublicationYear | 2011 |
Publisher | Springer US Springer Nature B.V Springer Verlag (Germany) |
Publisher_xml | – name: Springer US – name: Springer Nature B.V – name: Springer Verlag (Germany) |
References | KohnMCMelnickRLPhysiological modeling of butadiene disposition in mice and ratsChem Biol Interact2001136135301 KohnMCMelnickRLThe privileged access model of 1,3-butadiene dispositionEnviron Health Perspect20001085911917110360001:CAS:528:DC%2BD3cXnvV2kt74%3D10.2307/3454324 Melnick RL, Huff JE (1993) 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8,000 parts per million. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards. IARC Scientific Publications No. 127, Lyon BondJADahlARHendersonRFIrnbaumLSSpecies differences in the distribution of inhaled butadiene in tissuesAm Ind Hyg Assoc J19874886787236877321:CAS:528:DyaL2sXmtFehsLw%3D KohnMCMelnickRLSpecies differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, controlCarcinogenesis19931461962884723251:CAS:528:DyaK3sXisV2lu78%3D10.1093/carcin/14.4.619 LangLBaffling butadieneEnviron Health Perspect1994102328228580338671:STN:280:DyaK2czgslagsw%3D%3D Thornton-ManningRJDahlRABechtoldEWHendersonFRGender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposuresToxicology199611332232589019181:CAS:528:DyaK28XmvVCltLo%3D10.1016/0300-483X(96)03466-X Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Bauer C, Csanády GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and Styrene: Assessment of Health Hazards, vol IARC Scientific Publications No. 127, Lyon GelmanAEBoisFYJiangJPhysiological pharmacokinetics analysis using population modeling and informative prior distributionsJ Am Stat Assoc1996911400141210.2307/2291566 BoisFYSmithTJGelmanAEChangHYSmithAEOptimal design for a study of butadiene toxicokinetics in humansToxicol Sci199949213224104162661:CAS:528:DyaK1MXkt1yqurc%3D10.1093/toxsci/49.2.213 SweeneyMLHimmelsteinWMSchlosserMPMedinskyAMPhysiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneToxicology199611331832189019171:CAS:528:DyaK28XmvVCltL0%3D10.1016/0300-483X(96)03465-8 BoisFYMaszleDRMCSim: a Monte Carlo simulation programJ Stat Softw19972160 MezzettiMIbrahimJGBoisFYRyanLMNgoLSmithTJA Bayesian compartmental model for the evaluation of 1,3-Butadiene metabolismAppl Stat2003523291305 ShargelLYuAApplied biopharmaceutics and pharmacokinetics19994Stamford, CTAppleton and Lange3643 ATSDR (1993) ToxFAQsTM for 1,3-Butadiene. Atlanta, GA: U.S. Department of health and human services, Public Health Service. http://www.atsdr.cdc.gov/tfacts28.html. Accessed 20 Feb 2004 LeavensLTBondAJPharmacokinetic model describing the disposition of butadiene and styrene in miceToxicology199611331031389019151:CAS:528:DyaK28XmvVCltL8%3D10.1016/0300-483X(96)03463-4 HimmelsteinWMTurnerJMAsgharianBBondAJMetabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and miceToxicology199611330630989019141:CAS:528:DyaK28XmvVCltL4%3D10.1016/0300-483X(96)03462-2 LinYSSmithTJKelseyKTWypijDHuman physiologic factors in respiratory update of 1,3-butadieneEnviron Health Perspect2001109921926116731211:CAS:528:DC%2BD3MXnvVCkt78%3D10.1289/ehp.01109921 LinYSSmithTJWypijDKelseyKTSacksMFAssociation of blood/air partition coefficient of 1,3-butadiene with blood lipids and albuminEnviron Health Perspect20021102165168118361451:CAS:528:DC%2BD38Xit1ansL0%3D10.1289/ehp.02110165 SeatonJMPlopperGCBondAJ1,3-Butadiene metabolism by lung airways isolated from mice and ratsToxicology199611331431789019161:CAS:528:DyaK28XmvVCltLw%3D10.1016/0300-483X(96)03464-6 CsanadyAGKreuzerPEBaurCFilserJGA physiological toxicokinetic model for 1,3-Butadiene in rodents and man: blood concentrations of 1,3- butadiene, its metabolically form epoxides, and of haemoglobin adducts—relevance of glutathione depletionToxicology199611330030589019131:CAS:528:DyaK28XmvVClt7c%3D10.1016/0300-483X(96)03461-0 AE Gelman (124_CR7) 1996; 91 JM Seaton (124_CR18) 1996; 113 124_CR16 M Mezzetti (124_CR17) 2003; 52 AG Csanady (124_CR5) 1996; 113 RJ Thornton-Manning (124_CR21) 1996; 113 FY Bois (124_CR2) 1997; 2 L Lang (124_CR12) 1994; 102 L Shargel (124_CR19) 1999 ML Sweeney (124_CR20) 1996; 113 MC Kohn (124_CR10) 2000; 108 WM Himmelstein (124_CR8) 1996; 113 LT Leavens (124_CR13) 1996; 113 MC Kohn (124_CR9) 1993; 14 JA Bond (124_CR4) 1987; 48 124_CR6 124_CR1 YS Lin (124_CR14) 2001; 109 124_CR11 FY Bois (124_CR3) 1999; 49 YS Lin (124_CR15) 2002; 110 |
References_xml | – reference: BoisFYSmithTJGelmanAEChangHYSmithAEOptimal design for a study of butadiene toxicokinetics in humansToxicol Sci199949213224104162661:CAS:528:DyaK1MXkt1yqurc%3D10.1093/toxsci/49.2.213 – reference: SeatonJMPlopperGCBondAJ1,3-Butadiene metabolism by lung airways isolated from mice and ratsToxicology199611331431789019161:CAS:528:DyaK28XmvVCltLw%3D10.1016/0300-483X(96)03464-6 – reference: KohnMCMelnickRLPhysiological modeling of butadiene disposition in mice and ratsChem Biol Interact2001136135301 – reference: ShargelLYuAApplied biopharmaceutics and pharmacokinetics19994Stamford, CTAppleton and Lange3643 – reference: ATSDR (1993) ToxFAQsTM for 1,3-Butadiene. Atlanta, GA: U.S. Department of health and human services, Public Health Service. http://www.atsdr.cdc.gov/tfacts28.html. Accessed 20 Feb 2004 – reference: HimmelsteinWMTurnerJMAsgharianBBondAJMetabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and miceToxicology199611330630989019141:CAS:528:DyaK28XmvVCltL4%3D10.1016/0300-483X(96)03462-2 – reference: Melnick RL, Huff JE (1993) 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8,000 parts per million. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards. IARC Scientific Publications No. 127, Lyon – reference: MezzettiMIbrahimJGBoisFYRyanLMNgoLSmithTJA Bayesian compartmental model for the evaluation of 1,3-Butadiene metabolismAppl Stat2003523291305 – reference: BoisFYMaszleDRMCSim: a Monte Carlo simulation programJ Stat Softw19972160 – reference: LangLBaffling butadieneEnviron Health Perspect1994102328228580338671:STN:280:DyaK2czgslagsw%3D%3D – reference: CsanadyAGKreuzerPEBaurCFilserJGA physiological toxicokinetic model for 1,3-Butadiene in rodents and man: blood concentrations of 1,3- butadiene, its metabolically form epoxides, and of haemoglobin adducts—relevance of glutathione depletionToxicology199611330030589019131:CAS:528:DyaK28XmvVClt7c%3D10.1016/0300-483X(96)03461-0 – reference: GelmanAEBoisFYJiangJPhysiological pharmacokinetics analysis using population modeling and informative prior distributionsJ Am Stat Assoc1996911400141210.2307/2291566 – reference: Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Bauer C, Csanády GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and Styrene: Assessment of Health Hazards, vol IARC Scientific Publications No. 127, Lyon – reference: LinYSSmithTJKelseyKTWypijDHuman physiologic factors in respiratory update of 1,3-butadieneEnviron Health Perspect2001109921926116731211:CAS:528:DC%2BD3MXnvVCkt78%3D10.1289/ehp.01109921 – reference: LeavensLTBondAJPharmacokinetic model describing the disposition of butadiene and styrene in miceToxicology199611331031389019151:CAS:528:DyaK28XmvVCltL8%3D10.1016/0300-483X(96)03463-4 – reference: BondJADahlARHendersonRFIrnbaumLSSpecies differences in the distribution of inhaled butadiene in tissuesAm Ind Hyg Assoc J19874886787236877321:CAS:528:DyaL2sXmtFehsLw%3D – reference: Thornton-ManningRJDahlRABechtoldEWHendersonFRGender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposuresToxicology199611332232589019181:CAS:528:DyaK28XmvVCltLo%3D10.1016/0300-483X(96)03466-X – reference: LinYSSmithTJWypijDKelseyKTSacksMFAssociation of blood/air partition coefficient of 1,3-butadiene with blood lipids and albuminEnviron Health Perspect20021102165168118361451:CAS:528:DC%2BD38Xit1ansL0%3D10.1289/ehp.02110165 – reference: KohnMCMelnickRLSpecies differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, controlCarcinogenesis19931461962884723251:CAS:528:DyaK3sXisV2lu78%3D10.1093/carcin/14.4.619 – reference: KohnMCMelnickRLThe privileged access model of 1,3-butadiene dispositionEnviron Health Perspect20001085911917110360001:CAS:528:DC%2BD3cXnvV2kt74%3D10.2307/3454324 – reference: SweeneyMLHimmelsteinWMSchlosserMPMedinskyAMPhysiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneToxicology199611331832189019171:CAS:528:DyaK28XmvVCltL0%3D10.1016/0300-483X(96)03465-8 – volume: 48 start-page: 867 year: 1987 ident: 124_CR4 publication-title: Am Ind Hyg Assoc J doi: 10.1080/15298668791385723 – ident: 124_CR11 – volume: 110 start-page: 165 issue: 2 year: 2002 ident: 124_CR15 publication-title: Environ Health Perspect doi: 10.1289/ehp.02110165 – volume: 113 start-page: 306 year: 1996 ident: 124_CR8 publication-title: Toxicology doi: 10.1016/0300-483X(96)03462-2 – volume: 113 start-page: 314 year: 1996 ident: 124_CR18 publication-title: Toxicology doi: 10.1016/0300-483X(96)03464-6 – ident: 124_CR6 – volume: 113 start-page: 310 year: 1996 ident: 124_CR13 publication-title: Toxicology doi: 10.1016/0300-483X(96)03463-4 – volume: 102 start-page: 282 issue: 3 year: 1994 ident: 124_CR12 publication-title: Environ Health Perspect doi: 10.1289/ehp.102-1567096 – volume: 113 start-page: 322 year: 1996 ident: 124_CR21 publication-title: Toxicology doi: 10.1016/0300-483X(96)03466-X – volume: 108 start-page: 911 issue: 5 year: 2000 ident: 124_CR10 publication-title: Environ Health Perspect doi: 10.2307/3454324 – ident: 124_CR1 – ident: 124_CR16 – volume: 52 start-page: 291 issue: 3 year: 2003 ident: 124_CR17 publication-title: Appl Stat – start-page: 36 volume-title: Applied biopharmaceutics and pharmacokinetics year: 1999 ident: 124_CR19 – volume: 109 start-page: 921 year: 2001 ident: 124_CR14 publication-title: Environ Health Perspect doi: 10.1289/ehp.01109921 – volume: 2 start-page: 1 year: 1997 ident: 124_CR2 publication-title: J Stat Softw – volume: 113 start-page: 300 year: 1996 ident: 124_CR5 publication-title: Toxicology doi: 10.1016/0300-483X(96)03461-0 – volume: 14 start-page: 619 year: 1993 ident: 124_CR9 publication-title: Carcinogenesis doi: 10.1093/carcin/14.4.619 – volume: 113 start-page: 318 year: 1996 ident: 124_CR20 publication-title: Toxicology doi: 10.1016/0300-483X(96)03465-8 – volume: 49 start-page: 213 year: 1999 ident: 124_CR3 publication-title: Toxicol Sci doi: 10.1093/toxsci/49.2.213 – volume: 91 start-page: 1400 year: 1996 ident: 124_CR7 publication-title: J Am Stat Assoc doi: 10.2307/2291566 |
SSID | ssj0004125 |
Score | 1.8550329 |
Snippet | In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to... |
SourceID | hal proquest crossref springer fao |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 131 |
SubjectTerms | Age Bayesian analysis Biomedical and Life Sciences breathing Cancer Carcinogens Chemistry and Earth Sciences Computer Science Computer simulation Differential equations Ecology Environmental Sciences Estimates Estimating techniques females Gender gender differences Health Sciences Hispanic people Hispanics Human body Inhalation Intervals Life Sciences Males Markov analysis Markov chain Markov chains Math. Appl. in Environmental Science Mathematical models Medicine Metabolism Metabolites Monkeys & apes Monte Carlo methods Monte Carlo simulation Occupational safety Pharmacokinetics Physics Public health Race Statistics for Engineering Statistics for Life Sciences Steady state Studies Theoretical Ecology/Statistics Toxicology Tumors volunteers |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagCNQLj0DVUIqMBBeQpV2vvY9jQGkjBFwgUm_Wxo-A2m4Q2SDl3_ONd7cpiCJxyCpaTxwn4_F8s_Ni7KXMVB60zoSUdRAqc4mossQLQI2ysrbENQbIfspnc_X-TJ_1edzrIdp9cEnGk_pasluuYfrG-B6pBEyeOxqmO0njXE52yZBp7LSaAlmIEvp9cGX-bYrflNHtUK9w_UoBkdfQ5h8O0qh3Th6y-z1g5JOOw4_YLd-M2IOhGQPvZXPE7k5j_entiB1Md8lr-GRPsQbJqe9J7n3sXeq4GWNALYb3CXh2dZsfs3aKN4RmmyW_9C22ysU3y6muBAfM5YtNG2PFPK9bHjfKlsfcJE6B9Ete87f11lOCJo_PToYj9mIrSG863O1KZp9jEfhGHjvyPGHzk-mXdzPRd2gQFmZ1K2QI-EuVA6PB1VT6IvHOqUWwVa6dkzrzSShsDp2nbQXkhDGV-9xRN0Pp0uyA7TWrxh8yXvrgPE48rQFIk9IulAWWK3XIKg-Iosbs9cAq870rxGF2JZeJrwZ8NcRXk47ZIZhp6iUOSjP_LMmMxItK3Y_ZK3D4agqqrj2bfDCUaQlasugAaPOfmOJo2AOmF-u1KbWi4kQFVvPiahTySE6WuvGrzdqkBOEqchj_g6YoYEUnqsBq-A00JUFFSEwxZm-GHbhbyI2__Ol_UR-x_e4ZOcXUPWN77Y-NPwbIahfPo1D9As1rGd0 priority: 102 providerName: Springer Nature |
Title | Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model |
URI | https://link.springer.com/article/10.1007/s10651-009-0124-1 https://www.proquest.com/docview/854115774 https://www.proquest.com/docview/1663590464 https://www.proquest.com/docview/1777170476 https://www.proquest.com/docview/864399777 https://ineris.hal.science/ineris-00963266 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxNBFD7YFqEgotHSbbWMoC_K4F5mb0-SSi6oFFED9WnY7MxGUDe12Qj5935ndjdRoX3IJuwMm0m-M3O-mXMjeh5GKqniOJJhWFRSRcaXeeRbCaqR5WWZ4eocZC-S6Uy9u4wvO9-cVedW2a-JbqE2y5LPyF9nseK8MKl6c_VLctEoNq52FTT26CCAomExz8aTXVhk4GquBuAYMoOm742abeRcEmMf7ZyFQiWDf9TSXlUscf3GrpF_8c7_TKVOA40f0P2OOophi_VDumPrAR2NdpFqaOym6mpAdyeuZu9mQPfaoznRRhwN6JAJZpuf-RE1I3xg1lovxE_bQCS4K-ePEKCzYr5unE-YFUUjnEBshItBEuwwvxCFOC82lgMxhTsj6ZfSHxvJ-tHgbpsa-zvYLL5RuMo7j2k2Hn15O5VdJQZZYvvcyLCq8IcpA0CBXhDa1LfGqHlV5klsTBhH1q_SMoFui8scDAltKrGJ4aqFoQmiI9qvl7U9JpHZylisbDFj6WflXJXgbFlcRbkFFVEeveyB0Fdtwg29S63MqGmgphk1HXh0DKh0scCCqGefQ94u4sUp7T16Afy2j-As2tPhB80RlejLOzcQ1-Q3HnHaI6y76bvSW2Hz6Nm2FfOOjSlFbZfrlQ6YquVsGL6lT5pit-yrFKMRN_TJmBJiZqQeverlazeQG3_5ya3DPqXD9uybfeWe0H5zvbZPQZ6a-ZmbImd0MJx8fT_C-_no4uMn3J2Fwz_YUxaw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tnRCTEILCtDA-jMReQBaJY-fjAaENOjpWKgSrtDeTxk6RgHTQFJQ_iv-ROydpAWl720Ojqracq-58_p3vC-CJCGVUKBVyIbKCy9D4PA19yxFqJGmeJ_h0AbLjaDiRb8_U2Qb87nJhKKyy04lOUZt5TnfkzxMlqS5MLF-ef-fUNIqcq10HjUYqTmz9Cy22xYvj18jefSGOBqevhrxtKsBztAQrLooCrSBpkDYkJBA29q0xclrkaaSMESq0fhHnEapplad42OOYjGxkqAGfMEGI627ClqSE1h5sHQ7G7z-sEzED1-U1QFTDE8QWnRu1ydWLFFruLjxJSB78cxBuFtkcn58pGPMvpPufc9adeUe34GYLVtlBI123YcOWfdgZrHPjcLBVDos-XHvjugTXfbjRXAayJsepD9sEaZuK0HegGuAXwsnljH2zFQohTaWKFQwBNJsuKxeFZllWMSeCNXNZT4xC9GcsY4dZbSn1k7lbmU55f605ncgGf22KcX9B_IxvZK7Xz12YXAmbdqBXzku7CyyxhbGoSxVJj5_kU5kjSkxUEaYWwY_04GnHCH3elPjQ62LOxDWNXNPENR14sIus0tkMVbCefBRkoOKHiuh7sI_8Wy1BdbuHByNNOZw4l2xFhMrRT1xir-OwbhXGQq_E24PHq1Hc6eS-yUo7Xy50QOAwJVf0JXPiGO1zX8ZIDbtgTkIgFPdi7MGzTr7WhFz4z-9dSvYjuD48fTfSo-PxyR5sNzfvFKl3H3rVj6V9gNCtmj5sNwyDT1e9R_8ATuBQFg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tQ6BJE4LCtGx8GIm9gKwljp2PB4QGa9exaUKCSnszaWwXCWgHTUH50_jvuHOSFpC2tz00qmrLuerO59_5vgCei1gmTqmYC1E4LmMT8jwOLUeokeVlmeHTB8ieJ8ORfHehLtbgd5cLQ2GVnU70itrMSrojP8iUpLowqTxwbVTE-6PB68vvnBpIkaO166bRSMiprX-h9TZ_dXKErN4XYtD_-HbI2wYDvESrsOLCObSIpEE6kahI2DS0xsixK_NEGSNUbEOXlgmqbFXmePDjmExsYqgZnzBRjOuuw600TnOy-7LB8SolM_L9XiPENzxDlNE5VJusvUShDe8DlYTk0T9H4rorZvj8TGGZf2He_9y0_vQb3IO7LWxlh42c3Yc1O-3Bdn-VJYeDrZqY9-D2se8XXPdgq7kWZE22Uw82Cdw2taEfQNXHL4SYpxP2zVYojjSValcwhNJsvKh8PJplRcW8MNbM5z8xCtafsIK9KWpLSaDM3890avxrzelsNvhrU5b7CyJpfCPzXX8ewuhGmLQNG9PZ1O4Ay6wzFrWqIjkKs3IsS8SLmXJxbhEGyQBedIzQl02xD70q60xc08g1TVzTUQA7yCpdTFAZ69EHQaYqfqicfgD7yL_lElTBe3h4pimbE-eS1YigOfmJS-x1HNat6pjrpaAH8Gw5inueHDnF1M4Wcx0RTMzJKX3NnDRFSz2UKVLDrpiTERzFXZkG8LKTrxUhV_7z3WvJfgp3cGfqs5Pz0z3YbK7gKWTvEWxUPxb2MWK4avzE7xYGn256e_4BfedS5g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+metabolic+rate+for+butadiene+at+steady+state+using+a+Bayesian+physiologically-based+pharmacokinetic+model&rft.jtitle=Environmental+and+ecological+statistics&rft.au=Ngo%2C+Long&rft.au=Ryan%2C+Louise+M&rft.au=Mezzetti%2C+Maura&rft.au=Bois%2C+Fr%C3%A9d%C3%A9ric+Y&rft.date=2011-03-01&rft.issn=1352-8505&rft.volume=18&rft.issue=1+p.131-146&rft.spage=131&rft.epage=146&rft_id=info:doi/10.1007%2Fs10651-009-0124-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-8505&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-8505&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-8505&client=summon |